Organon (OGN)
Commercializes women's health medicines, biosimilars, and established brands.
$13.72
vs last close+0.02 (+0.15%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 47 days
EPS estimate
$0.91
Revenue estimate
$1.58B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26Apr '26Jul '26Nov '26
Reported$0.90$1.02$1.00$1.01$0.63$0.71$0.85Pending
Estimate$0.92$0.89$0.94$0.93$0.73$0.83$0.85$0.91
Surprise−2.2%+14.6%+6.4%+8.6%−13.7%−14.5%0.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26Apr '26Jul '26Nov '26
Reported$1.59B$1.51B$1.59B$1.60B$1.51B$1.46B$1.60BPending
Estimate$1.59B$1.54B$1.56B$1.52B$1.53B$1.49B$1.60B$1.58B
Surprise0.0%−1.5%+2.1%+5.3%−1.8%−1.9%0.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.84 | — | — |
| Sep 2027 | $0.89 | — | — |
| Jun 2027 | $0.89 | — | — |
| Mar 2027 | $0.79 | — | — |
| Dec 2026 | $0.92 | — | — |
| Nov 2026 | $0.91 | — | — |
| Jul 2026 | $0.85 | $0.85 | 0.0% |
| Apr 2026 | $0.83 | $0.71 | −14.5% |
| Feb 2026 | $0.73 | $0.63 | −13.7% |
| Nov 2025 | $0.93 | $1.01 | +8.6% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jun 2021 | |||
| Dec 2020 | |||
| Mar 2021 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.84 | — | — | $1.51B | — | — | — |
| Sep 2027 | $0.89 | — | — | $1.55B | — | — | — |
| Jun 2027 | $0.89 | — | — | $1.52B | — | — | — |
| Mar 2027 | $0.79 | — | — | $1.42B | — | — | — |
| Dec 2026 | $0.92 | — | — | $1.54B | — | — | — |
| Nov 9, 2026 | $0.91 | — | — | $1.58B | — | — | — |
| Jul 31, 2026 | $0.85 | $0.85 | 0.0% | $1.60B | $1.60B | 0.0% | 0.0% |
| Apr 30, 2026 | $0.83 | $0.71 | −14.5% | $1.49B | $1.46B | −1.9% | −0.7% |
| Feb 12, 2026 | $0.73 | $0.63 | −13.7% | $1.53B | $1.51B | −1.8% | −8.2% |
| Nov 10, 2025 | $0.93 | $1.01 | +8.6% | $1.52B | $1.60B | +5.3% | +13.7% |
| Aug 5, 2025 | |||||||
| May 1, 2025 | |||||||
| Feb 13, 2025 | |||||||
| Oct 31, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 2, 2024 | |||||||
| Feb 15, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 16, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 17, 2022 | |||||||
| Nov 11, 2021 | |||||||
| Aug 12, 2021 | |||||||
| Jun 21, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Mar 17, 2021 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |